Market Place
Sourcing Support
Keytruda Hangs On To Best Seller Crown As Glp-1s Gain Ground
04 Mar 2026 //
BIOSPACE
Keytruda + Welireg Cuts RCC Recurrence 28% VS Placebo
28 Feb 2026 //
BUSINESSWIRE
Merck`s Welireg combos deliver 1-2 punch to kidney cancer
28 Feb 2026 //
FIERCE PHARMA
Padcev-Keytruda Combo Wins in MIBC Amid Evolving Landscape
28 Feb 2026 //
FIERCE PHARMA
Keytruda Combo Improves OS in Platinum-Resistant Ovarian Cancer
27 Feb 2026 //
BUSINESSWIRE
Merck, Working Through Gardasil Demand Woes, Cuts Jobs In NC
27 Feb 2026 //
FIERCE PHARMA
Synthekine, Merck Launch STK-012/Keytruda Trial for NSCLC Cancer
26 Feb 2026 //
BUSINESSWIRE
MSD appoints Brecht Vanneste as MD for India
26 Feb 2026 //
EXPRESSPHARMA
Gilead, Merck Clear Path for Daily HIV Pills with Late-Stage Data
26 Feb 2026 //
BIOSPACE
FDA Greenlights NUMELVI For Canine Allergic Dermatitis By Merck
25 Feb 2026 //
BUSINESSWIRE
Merck Shares Late-Breaking Ph 3 DOR/ISL Data at CROI 2026
25 Feb 2026 //
BUSINESSWIRE
Merck Joins TD Cowen 46th Health Care Conference
24 Feb 2026 //
PHARMIWEB
Merck Restructures To Enhance Human Health Portfolio Execution
23 Feb 2026 //
PHARMIWEB
Merck Reorganizes Human Health Work Into Two New Units
23 Feb 2026 //
BIOSPACE
Merck Shows Positive ENFLONSIA Data for High-Risk Infants
19 Feb 2026 //
PHARMIWEB
Merck, Mayo Clinic Launch AI Precision Medicine R&D Collaboration
18 Feb 2026 //
BUSINESSWIRE
Merck to Present New Bladder, Kidney Cancer Data at 2026 ASCO
12 Feb 2026 //
BUSINESSWIRE
Keytruda Combo Approved for Platinum-Resistant Ovarian Cancer
12 Feb 2026 //
FDA
Merck Teams Up With British Medtech Calla Lily
10 Feb 2026 //
FIERCE BIOTECH
Immutep Reaches 50% Enrollment In Global Phase III Trial For 1L
06 Feb 2026 //
GLOBENEWSWIRE
NMPA Approves Promega MSI Kit as KEYTRUDA Companion Diagnostic
03 Feb 2026 //
PHARMIWEB
Merck Announces 2025 Financial Results, Pipeline Progress
03 Feb 2026 //
PHARMIWEB
Merck lines up $70B+ in revenue opportunities over next decade
03 Feb 2026 //
FIERCE PHARMA
Merck Announces Second-Quarter 2026 Dividend
27 Jan 2026 //
BUSINESSWIRE
Pfizer Retains Top Spot In Vaccine Rankings As Sanofi Slides
27 Jan 2026 //
FIERCE PHARMA
Merck Backs Off Revolution After Failing To Agree On Price: WSJ
26 Jan 2026 //
BIOSPACE
CEPI Funds $30M Ebola Vaccine Collab With Merck, SK And Others
22 Jan 2026 //
FIERCE PHARMA
Merck, Moderna Sustain 49% Melanoma Risk Reduction At 5 Years
22 Jan 2026 //
FIERCE BIOTECH
Guardant Health, Merck Partner To Develop Cancer Therapies
19 Jan 2026 //
BUSINESSWIRE
FDA Lifts Hold On Merck, Daiichi`s Lung Cancer ADC Trial
13 Jan 2026 //
BIOSPACE
Merck Confident In Growth Despite Keytruda Exclusivity Loss
13 Jan 2026 //
BIOSPACE
Merck Starts Phase 3 Trial Of Calderasib With Keytruda For NSCLC
11 Jan 2026 //
INDPHARMAPOST
Merck in Talks to Buy Drugmaker Revolution Med for up to $32B
10 Jan 2026 //
FINANCIAL TIMES
Merck Starts Phase 3 Trial of KRAS G12C Drug With Keytruda QLEX
07 Jan 2026 //
PHARMIWEB
Merck Plans Q4 & Full-Year 2025 Sales & Earnings Call On Feb. 3
07 Jan 2026 //
PHARMIWEB
Merck To Complete Acquisition Of Cidara Therapeutics
07 Jan 2026 //
PHARMIWEB
Merck Joins 44Th J.P. Morgan Healthcare Conference
05 Jan 2026 //
BUSINESSWIRE
Enforcement Report - Week of December 31, 2025
31 Dec 2025 //
FDA
Evaxion provides update on MSD collab For Gonorrhea EVX-B2
20 Dec 2025 //
FIERCE BIOTECH
FDA Grants Priority Vouchers to Merck`s Drugs
20 Dec 2025 //
REUTERS
Merck Expands Medicine Access, Lowers Costs For Americans
19 Dec 2025 //
BUSINESSWIRE
FDA Eyes Vouchers for Merck`s Two Blockbusters
18 Dec 2025 //
BIOSPACE
Daiichi-Merck Ph. 3 ADC Program On Pause After Patient Deaths
18 Dec 2025 //
FIERCE BIOTECH
Adagene Reveals FDA Fast Track For Muzastotug In Cancer
16 Dec 2025 //
GLOBENEWSWIRE
Merck Get Positive EU CHMP Opinion for Expanded Use of Winrevair
12 Dec 2025 //
PHARMIWEB
FDA Launches Probe Into Safety Of Approved Anti-RSV Antibodies
10 Dec 2025 //
BIOSPACE
Merck, Sanofi, AZ Shots For RSV Now Under Scrutiny By FDA
09 Dec 2025 //
FIERCE PHARMA
BenchSci, Merck Extend ASCEND for Disease Biology
09 Dec 2025 //
PHARMIWEB
Merck mulls PV program’s future while Takeda takes victory lap
08 Dec 2025 //
FIERCE BIOTECH
Merck`s Keytruda SC Launch In Germany Faces Legal Hurdle
05 Dec 2025 //
FIERCE PHARMA
FDA Approves Merck`s EXZOLT for New World Screwworm Larvae
04 Dec 2025 //
BUSINESSWIRE
Halozyme Secures Injunction On Merck`s Keytruda SC In Germany
04 Dec 2025 //
PR NEWSWIRE
Merck Announces Winners Of The Merck Young Scientist Award 2025
03 Dec 2025 //
EXPRESSPHARMA
Merck Unveils Alzheimer`s Data on MK-2214, MK-1167 at CTAD 2025
01 Dec 2025 //
PHARMIWEB
Merck Joins Citi 2025 Global Healthcare Conference
26 Nov 2025 //
BUSINESSWIRE
Merck Joins 8Th Evercore ISI Healthconx Conference
26 Nov 2025 //
BUSINESSWIRE
Kelun-Biotech Initiates Phase III Trial For SAC-TMT with Keytruda
24 Nov 2025 //
PR NEWSWIRE
Merck To Present Hematology Pipeline Advancements At ASH 2025
24 Nov 2025 //
BUSINESSWIRE
FDA Approves Combo Therapy For Ineligible Bladder Cancer Patients
23 Nov 2025 //
INDPHARMAPOST
Merck`s WINREVAIR Promising In Phase 2 Study For Pulmonary
21 Nov 2025 //
INDPHARMAPOST
